메뉴 건너뛰기




Volumn 63, Issue 5, 1998, Pages 540-551

Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CAFFEINE; PHENACETIN O DEETHYLASE; XANTHINE OXIDASE;

EID: 0031863228     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90105-9     Document Type: Article
Times cited : (78)

References (40)
  • 1
    • 0028237729 scopus 로고
    • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
    • Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 1994;270:414-23.
    • (1994) J Pharmacol Exp Ther , vol.270 , pp. 414-423
    • Shimada, T.1    Yamazaki, H.2    Mimura, M.3    Inui, Y.4    Guengerich, F.P.5
  • 2
    • 0029131555 scopus 로고
    • Clinical importance of hepatic cytochrome P450 in drug metabolism
    • Spatzenegger M, Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev 1995;27:397-417.
    • (1995) Drug Metab Rev , vol.27 , pp. 397-417
    • Spatzenegger, M.1    Jaeger, W.2
  • 3
    • 0028336794 scopus 로고
    • Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: Absence of mutation prescribing the phenotype in the CYP1A2 gene
    • Nakajima M, Yokoi T, Mizutani M, Shin S, Kadlubar FF, Kamataki T. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene. Cancer Epidemiol Biomarkers Prev 1994;3:413-21.
    • (1994) Cancer Epidemiol Biomarkers Prev , vol.3 , pp. 413-421
    • Nakajima, M.1    Yokoi, T.2    Mizutani, M.3    Shin, S.4    Kadlubar, F.F.5    Kamataki, T.6
  • 4
    • 0026094528 scopus 로고
    • Use of caffeine metabolic ratios to explore CYP1A2 and xanthine oxidase activities
    • Kalow W, Tang BK. Use of caffeine metabolic ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 1991;50:508-19.
    • (1991) Clin Pharmacol Ther , vol.50 , pp. 508-519
    • Kalow, W.1    Tang, B.K.2
  • 5
    • 0026879487 scopus 로고
    • Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites
    • Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, et al. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 1992;2:116-27.
    • (1992) Pharmacogenetics , vol.2 , pp. 116-127
    • Butler, M.A.1    Lang, N.P.2    Young, J.F.3    Caporaso, N.E.4    Vineis, P.5    Hayes, R.B.6
  • 6
    • 0021813284 scopus 로고
    • N-Acetylation pharmacogenetics
    • Weber WW, Hein DW. N-Acetylation pharmacogenetics. Pharmacol Rev 1985;37:25-79.
    • (1985) Pharmacol Rev , vol.37 , pp. 25-79
    • Weber, W.W.1    Hein, D.W.2
  • 7
    • 0002202499 scopus 로고
    • N-Acetyltransferase
    • Kalow W, editor. New York: Pergamon Press
    • Evans DAP. N-Acetyltransferase. In: Kalow W, editor. Pharmacogenetics of drug metabolism. New York: Pergamon Press; 1992. p. 95-178.
    • (1992) Pharmacogenetics of Drug Metabolism , pp. 95-178
    • Evans, D.A.P.1
  • 8
    • 0021798210 scopus 로고
    • Genetically determined variability in acetylation and oxidation: Therapeutic implications
    • Clark DWJ. Genetically determined variability in acetylation and oxidation: therapeutic implications. Drugs 1985;29:342-75.
    • (1985) Drugs , vol.29 , pp. 342-375
    • Clark, D.W.J.1
  • 10
    • 0019990268 scopus 로고
    • Ethnic differences in drug metabolism
    • Kalow W. Ethnic differences in drug metabolism. Clin Pharmacokinet 1982;7:373-400.
    • (1982) Clin Pharmacokinet , vol.7 , pp. 373-400
    • Kalow, W.1
  • 11
    • 0017398371 scopus 로고
    • Clinical consequences of polymorphic acetylation of basic drugs
    • Drayer DE, Reidenberg MM. Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther 1977;22:251-8.
    • (1977) Clin Pharmacol Ther , vol.22 , pp. 251-258
    • Drayer, D.E.1    Reidenberg, M.M.2
  • 12
    • 0019976311 scopus 로고
    • Role of N-acetyltransferase phenotypes in bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
    • Cartwright RA, Glasham RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, et al. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982;2:842-6.
    • (1982) Lancet , vol.2 , pp. 842-846
    • Cartwright, R.A.1    Glasham, R.W.2    Rogers, H.J.3    Ahmad, R.A.4    Barham-Hall, D.5    Higgins, E.6
  • 13
    • 0024235283 scopus 로고
    • Genetic polymorphism and cancer susceptibility: Evidence concerning acetyltransferases and cancer of the urinary bladder
    • Hein DW. Genetic polymorphism and cancer susceptibility: evidence concerning acetyltransferases and cancer of the urinary bladder. Bioessays 1988;9:200-4.
    • (1988) Bioessays , vol.9 , pp. 200-204
    • Hein, D.W.1
  • 14
    • 0016281733 scopus 로고
    • A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase
    • Kretnitsky TA, Tuttle JV, Cattau EL, Wang P. A comparison of the distribution and electron acceptor specificities of xanthine oxidase and aldehyde oxidase. Comp Biochem Physiol 1974;49B:687-703.
    • (1974) Comp Biochem Physiol , vol.49 B , pp. 687-703
    • Kretnitsky, T.A.1    Tuttle, J.V.2    Cattau, E.L.3    Wang, P.4
  • 15
    • 0022001353 scopus 로고
    • Variability of caffeine metabolism in humans
    • Kalow W. Variability of caffeine metabolism in humans. Drug Res 1985;35:319-24.
    • (1985) Drug Res , vol.35 , pp. 319-324
    • Kalow, W.1
  • 16
    • 0026346078 scopus 로고
    • Human liver xanthine oxidase: Nature and extent of individual variation
    • Guerciolini R, Szumlanski C, Weinshilboum RM. Human liver xanthine oxidase: nature and extent of individual variation. Clin Pharmacol Ther 1991;50:663-72.
    • (1991) Clin Pharmacol Ther , vol.50 , pp. 663-672
    • Guerciolini, R.1    Szumlanski, C.2    Weinshilboum, R.M.3
  • 17
    • 0023227456 scopus 로고
    • A urinary metabolite ratio that reflects systemic caffeine clearance
    • Campell ME, Spielberg SP, Kalow W. A urinary metabolite ratio that reflects systemic caffeine clearance. Clin Pharmacol Ther 1987;42:157-65.
    • (1987) Clin Pharmacol Ther , vol.42 , pp. 157-165
    • Campell, M.E.1    Spielberg, S.P.2    Kalow, W.3
  • 18
    • 0021151820 scopus 로고
    • A simple test for acetylator phenotype using caffeine
    • Grant DM, Tang BK, Kalow W. A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol 1984;17:459-64.
    • (1984) Br J Clin Pharmacol , vol.17 , pp. 459-464
    • Grant, D.M.1    Tang, B.K.2    Kalow, W.3
  • 20
    • 0027922323 scopus 로고
    • Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs
    • Food and Drug Administration. Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs. Federal Register 1993;58:39406-16.
    • (1993) Federal Register , vol.58 , pp. 39406-39416
  • 21
    • 0021322739 scopus 로고
    • Sex related differences in drug disposition in man
    • Wilson K. Sex related differences in drug disposition in man. Clin Pharmacokinet 1984;9:189-202.
    • (1984) Clin Pharmacokinet , vol.9 , pp. 189-202
    • Wilson, K.1
  • 22
    • 0029128720 scopus 로고
    • Gender effects in pharmacokinetics and pharmacodynamics
    • Harris RZ, Benet LZ, Schwartz JB. Gender effects in pharmacokinetics and pharmacodynamics. Drugs 1995; 50:222-39.
    • (1995) Drugs , vol.50 , pp. 222-239
    • Harris, R.Z.1    Benet, L.Z.2    Schwartz, J.B.3
  • 23
    • 0026621673 scopus 로고
    • Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities
    • Relling MV, Lin JS, Ayers GD, Evans WE. Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther 1992;52:643-58.
    • (1992) Clin Pharmacol Ther , vol.52 , pp. 643-658
    • Relling, M.V.1    Lin, J.S.2    Ayers, G.D.3    Evans, W.E.4
  • 24
  • 25
    • 0029769679 scopus 로고    scopus 로고
    • The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: A comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate
    • Bartoli A, Xiaodong S, Gatti G, Cipolla G, Marchiselli R, Perucca E. The influence of ethnic factors and gender on CYP1A2-mediated drug disposition: a comparative study in Caucasian and Chinese subjects using phenacetin as a marker substrate. Ther Drug Monit 1996;18:586-91.
    • (1996) Ther Drug Monit , vol.18 , pp. 586-591
    • Bartoli, A.1    Xiaodong, S.2    Gatti, G.3    Cipolla, G.4    Marchiselli, R.5    Perucca, E.6
  • 26
    • 0026467095 scopus 로고
    • Menstrual cycle effects on caffeine elimination in the human female
    • Lane JD, Steege JF, Rupp SL, Kühn CM. Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol 1992;43:543-6.
    • (1992) Eur J Clin Pharmacol , vol.43 , pp. 543-546
    • Lane, J.D.1    Steege, J.F.2    Rupp, S.L.3    Kühn, C.M.4
  • 29
    • 0021858734 scopus 로고
    • Distribution of acetylator phenotype in relation to age and sex in Swedish patients
    • Paulsen O, Nilsson LG. Distribution of acetylator phenotype in relation to age and sex in Swedish patients. Eur J Clin Pharmacol 1985;28:311-5.
    • (1985) Eur J Clin Pharmacol , vol.28 , pp. 311-315
    • Paulsen, O.1    Nilsson, L.G.2
  • 30
    • 0023274984 scopus 로고
    • Influence of age, sex and body weight on the dapsone acetylation phenotype
    • Philip PA, Gayed SL, Rogers HJ, Crome P. Influence of age, sex and body weight on the dapsone acetylation phenotype. Br J Clin Pharmacol 1987;23:709-13.
    • (1987) Br J Clin Pharmacol , vol.23 , pp. 709-713
    • Philip, P.A.1    Gayed, S.L.2    Rogers, H.J.3    Crome, P.4
  • 31
    • 0030951759 scopus 로고    scopus 로고
    • Acetylator phenotype in relation to age and gender in the Baltimore longitudinal study of aging
    • Korrapati MR, Sorkin JD, Andres R, Muller CD, Loe C, Vesell ES, et al. Acetylator phenotype in relation to age and gender in the Baltimore longitudinal study of aging. J Clin Pharmacol 1997;37:83-91.
    • (1997) J Clin Pharmacol , vol.37 , pp. 83-91
    • Korrapati, M.R.1    Sorkin, J.D.2    Andres, R.3    Muller, C.D.4    Loe, C.5    Vesell, E.S.6
  • 32
    • 0028333956 scopus 로고
    • Caffeine as a probe for CYP1A2 activity: Potential influence of renal factors on urinary phenotypic trait measurements
    • Tang KB, Zhou Y, Kadar D, Kalow W. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements. Pharmacogenetics 1994;4:117-24.
    • (1994) Pharmacogenetics , vol.4 , pp. 117-124
    • Tang, K.B.1    Zhou, Y.2    Kadar, D.3    Kalow, W.4
  • 33
    • 0019362251 scopus 로고
    • Introduction to sample size determination and power analysis for clinical trials
    • Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials 1981;2:93-113.
    • (1981) Control Clin Trials , vol.2 , pp. 93-113
    • Lachin, J.M.1
  • 34
    • 0024379208 scopus 로고
    • Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children
    • Evans WH, Relling MV, Petros WP, Meyer WH, Mirro J Jr, Crom WR. Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children. Clin Pharmacol Ther 1989;45:568-73.
    • (1989) Clin Pharmacol Ther , vol.45 , pp. 568-573
    • Evans, W.H.1    Relling, M.V.2    Petros, W.P.3    Meyer, W.H.4    Mirro Jr., J.5    Crom, W.R.6
  • 36
    • 0025892853 scopus 로고
    • Caffeine as a metabolic probe: Validation of its use for acetylator phenotyping
    • Tang BK, Kadar D, Qian L, Iriah J, Yip J, Kalow W. Caffeine as a metabolic probe: validation of its use for acetylator phenotyping. Clin Pharmacol Ther 1991;49:648-57.
    • (1991) Clin Pharmacol Ther , vol.49 , pp. 648-657
    • Tang, B.K.1    Kadar, D.2    Qian, L.3    Iriah, J.4    Yip, J.5    Kalow, W.6
  • 37
    • 7844249176 scopus 로고
    • Evanston (IL): SYSTAT Intelligent Software
    • SYSTAT user's guide. Evanston (IL): SYSTAT Intelligent Software; 1990.
    • (1990) SYSTAT User's Guide
  • 38
    • 0016278917 scopus 로고
    • Gentamicin pharmacokinetics
    • Devine BJ. Gentamicin pharmacokinetics. Drug Intell Clin Pharm 1974;8:650-5.
    • (1974) Drug Intell Clin Pharm , vol.8 , pp. 650-655
    • Devine, B.J.1
  • 39
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MDH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.D.H.2
  • 40
    • 0025055648 scopus 로고
    • Enzyme induction in the cytochrome P-450 system
    • Okey AB. Enzyme induction in the cytochrome P-450 system. Pharmacol Ther 1990;45:241-98.
    • (1990) Pharmacol Ther , vol.45 , pp. 241-298
    • Okey, A.B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.